United Therapeutics | UTHR - Fremdkapital





Fremdkapital Veränderung Datum
Ardelyx USD 202.83M 696K 2025-12
Baxter International USD 8.62B 852M 2026-03
Bayer EUR 30.68B 1.15B 2026-03
BioCryst Pharmaceuticals USD 395.2M 33.48M 2026-03
Biogen USD 6.29B 1.7M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 20.86B 1.27B 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
Halozyme Therapeutics USD 1.94B 206.73M 2026-03
Insmed USD 542.22M 1.25M 2026-03
Ionis Pharmaceuticals USD 1.91B 9M 2026-03
J&J USD 37.53B 1.91B 2026-03
Lexicon Pharmaceuticals USD 49.68M 276K 2026-03
Moderna USD 603M 7M 2026-03
Omeros USD 403.72M 27.2M 2024-06
Pfizer USD 60.57B 1.08B 2026-03
PTC Therapeutics USD 286.94M 1.74B 2026-03
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 838.16M 9.19M 2026-03
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12